Serveur d'exploration sur les pandémies grippales - Checkpoint (Istex)

Index « Teeft.i » - entrée « Cost effectiveness »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Cost data < Cost effectiveness < Cost effectiveness calculations  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 15.
Ident.Authors (with country if any)Title
000605 (2012) Anna K. Lugnér [Pays-Bas] ; Michiel Van Boven [Pays-Bas] ; Robin De Vries [Pays-Bas] ; Maarten J. Postma [Pays-Bas] ; Jacco Wallinga [Pays-Bas]Cost effectiveness of vaccination against pandemic influenza in European countries: mathematical modelling analysis
000C22 (2010) Tony DelamotheHalf a billion here, half a billion there
001059 (2009) Margaret L. Brandeau [États-Unis] ; Jessica H. Mccoy [États-Unis] ; Nathaniel Hupert [États-Unis] ; Jon-Erik Holty [États-Unis] ; Dena M. Bravata [États-Unis]Recommendations for Modeling Disaster Responses in Public Health and Medicine: A Position Paper of the Society for Medical Decision Making
001427 (2008) 29TH ANNUAL MEETING OF THE SOCIETY FOR MEDICAL DECISION MAKING
001680 (2007) 2006 EUROPEAN SOCIETY FOR MEDICAL DECISION MAKING MEETING
001966 (2005) Rebecca Coombes [Royaume-Uni]UK stocks up on antiviral drug to tackle flu outbreak
001996 (2005) Zosia Kmietowicz [Royaume-Uni]NICE proposes to withdraw Alzheimer's drugs from NHS
001A09 (2005) S S S. Teo [Royaume-Uni] ; J S Nguyen-Van-Tam [Royaume-Uni] ; R. Booy [Royaume-Uni]Influenza burden of illness, diagnosis, treatment, and prevention: what is the evidence in children and where are the gaps?
001D17 (2001) Karen A. Fitzner [République populaire de Chine] ; K. F Shortridge [République populaire de Chine] ; S. M Mcghee [République populaire de Chine] ; A. J Hedley [République populaire de Chine]Cost-effectiveness study on influenza prevention in Hong Kong
001D70 (2000) George AveryOutsourcing Public Health Laboratory Services: A Blueprint for Determining Whether to Privatize and How
001E86 (1997) Editorials
001E89 (1997) R T Mayon WhiteWhen the next influenza pandemic comes
001E92 (1997) Alan Maynard ; Karen BloorRegulating the pharmaceutical industry
001E93 (1997) G Justus Hofmeyr [Afrique du Sud] ; James Mcintyre [Afrique du Sud]Preventing perinatal infections
001E95 (1997) Richard SmithMisconduct in research: editors respond

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/PandemieGrippaleV1/Data/Istex/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Teeft.i -k "Cost effectiveness" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Teeft.i  \
                -Sk "Cost effectiveness" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    PandemieGrippaleV1
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Teeft.i
   |clé=    Cost effectiveness
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Wed Jun 10 11:04:28 2020. Site generation: Sun Mar 28 09:10:28 2021